| Elizabeth Maeve Nolan, MS CCC-SLP | |
|
4560 W 103rd St Ste 2, Oak Lawn, IL 60453-4870 | |
| (708) 860-5015 | |
| Not Available |
| Full Name | Elizabeth Maeve Nolan |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 4560 W 103rd St Ste 2, Oak Lawn, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013428788 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 146.013774 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Maeve Nolan, MS CCC-SLP 4560 W 103rd St Ste 2, Oak Lawn, IL 60453-4870 Ph: () - | Elizabeth Maeve Nolan, MS CCC-SLP 4560 W 103rd St Ste 2, Oak Lawn, IL 60453-4870 Ph: (708) 860-5015 |
News Archive
Researchers from the University of California, Irvine have conducted a statistical analysis that predicts more than 70,000 heart attacks, strokes and other adverse cardiovascular events could be prevented each year in the U.S. through the use of a highly purified fish oil therapy.
A promising new test is detecting prostate cancer more precisely than current tests, by identifying molecular changes in the prostate specific antigen (PSA) protein, according to Cleveland Clinic research presented today at the American Urological Association annual meeting.
Response Genetics, Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, today announced it has signed a non-exclusive license agreement with GlaxoSmithKline ("GSK"). Under the terms of the agreement, GSK gains certain rights to Response Genetics' proprietary PCR analysis technology and diagnostic expertise to assess BRAF gene mutations in human tumor samples. Payments will be made to Response Genetics upon achivement of agreed-to milestones.
New results from the Treatment Options for Type 2 Diabetes in Youth study (TODAY) examined predictors of the outcomes in youth with onset type 2 diabetes (T2D) based on early characteristics at diagnosis, and suggests the need for specific criteria for adolescents that are different from those in adults.
› Verified 8 days ago
Traci Lynn Tague, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4440 W 95th St, Oak Lawn, IL 60453 Phone: 708-684-1989 | |
Anna Manilla, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4440 W 95th St, Oak Lawn, IL 60453 Phone: 248-701-7523 | |
Erin M Shannon, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4300 W 108th Pl, Oak Lawn, IL 60453 Phone: 708-423-3078 | |
Jennifer Andrekus, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9830 Brandt Ave, Oak Lawn, IL 60453 Phone: 708-423-7820 | |
Noreen Philbin, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10620 S Kolin Ave, Oak Lawn, IL 60453 Phone: 708-228-1498 | |
Emily Quinn, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10201 S Cicero Ave Ste F, Oak Lawn, IL 60453 Phone: 815-469-1500 Fax: 779-216-3069 |